Publications - sorted by Principle Investigators

Last year | Last five years | All

Muratspahić E, Tomašević N, Nasrollahi-Shirazi S, Gattringer J, Emser FS, Freissmuth M, Gruber CW (2021) Plant-Derived Cyclotides Modulate κ-Opioid Receptor Signaling. J Nat Prod, 84(8): 2238-2248
Bhat S, Guthrie DA, Kasture A, El-Kasaby A, Cao J, Bonifazi A, Ku T, Giancola JB, Hummel T, Freissmuth M, Newman AH (2021) Tropane-based ibogaine analog rescues folding-deficient serotonin and dopamine transporters. ACS, 4: 503-516
191. Ng J, Barral S, De La Fuente Barrigon C, Lignani G, Erdem FA, Wallings R, Privolizzi R, Rossignoli G, Alrashidi H, Heasman S, Meyer E, Ngoh A, Pope S, Karda R, Perocheau D, Baruteau J, Suff N, Antinao Diaz J, Schorge S, Vowles J, Marshall LR, Cowley SA, Sucic S, Freissmuth M, Counsell J, Wade-Martins R, Heales SJR, Rahim AA, Bencze M, Waddington SN, Kurian MA (2021) Gene therapy restores dopamine transporter expression and ameliorates pathology in iPSC and mouse models of infantile parkinsonism. Sci Transl Med, 13(594): eaaw1564
Esendir E, Burtscher V, Coleman JA, Zhu R, Gouaux E, Freissmuth M, Sandtner W (2021) Extracellular loops of the serotonin transporter act as a selectivity filter for drug binding J Biol Chem, 297(1): 00863

Burtscher V, Hotka M, Freissmuth M, Sandtner W (2020) An electrophysiological approach to measure changes in the membrane surface potential in real time Biophys. J, 118(4): 813-825
Nasrollahi-Shirazi S, Szöllösi D, Yang Q, Muratspahic E, El-Kasaby A, Sucic S, Stockner T, Nanoff C, Freissmuth M (2020) Functional impact of the G279S substitution in the adenosine A1-receptor (A1R-G279S), a mutation associated with Parkinson's disease Mol Pharmacol, 98: 250–266